logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 8106069 B1

PDFFull Text
Date of Patent:
Jan. 31, 2012

Filed:

Apr. 23, 2010

Pyrrolo[2,3-b]pyridine derivatives active as kinase inhibitors and pharmaceutical compositions comprising them

Applicants:

Barbara Salom, Milan, IT;

Matteo D'anello, Milan, IT;

Maria Gabriella Brasca, Milan, IT;

Patrizia Giordano, Cuneo, IT;

Katia Martina, Novara, IT;

Francesco Angelucci, Milan, IT;

Frederick Arthur Brookfield, Oxon, GB;

William John Trigg, Oxon, GB;

Edward Andrew Boyd, Berkshire, GB;

Jonathan Anthony Larard, York, GB;

Inventors:

Barbara Salom, Milan, IT;

Matteo D'Anello, Milan, IT;

Maria Gabriella Brasca, Milan, IT;

Patrizia Giordano, Cuneo, IT;

Katia Martina, Novara, IT;

Francesco Angelucci, Milan, IT;

Frederick Arthur Brookfield, Oxon, GB;

William John Trigg, Oxon, GB;

Edward Andrew Boyd, Berkshire, GB;

Jonathan Anthony Larard, York, GB;

Assignee:

Pfizer Italia S.r.l., Rome, IT;

Attorney:

Scully, Scott, Murphy & Presser, P.C.

Primary Examiner:

Andrew D Kosar

Assistant Examiner:

Raymond Covington

Int. Cl.
CPC ...
A61K 31/44 (2006.01); A61K 31/50 (2006.01); A61K 31/497 (2006.01); A61K 31/445 (2006.01);
U.S. Cl.
CPC ...
Abstract

Compounds which are pyrrolo[2,3-b]pyridine derivatives or pharmaceutically acceptable salts thereof, their preparation process and pharmaceutical compositions comprising them are disclosed; these compounds are useful in the treatment of diseases caused by and/or associated with an altered protein kinase activity such as cancer, cell proliferative disorders, Alzheimer's disease, viral infections, auto-immune diseases and neurodegenerative disorders; also disclosed is a process under SPS conditions for preparing the compounds of the invention and chemical libraries comprising a plurality of them.

Find Patent Forward Citations

Salom, Barbara. (2012). Pyrrolo[2,3-b]pyridine derivatives active as kinase inhibitors and pharmaceutical compositions comprising them (U.S. Patent No. 8106069). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/8106069

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…